-
1
-
-
0035888074
-
Estimating the world cancer burden: Globocan 2000
-
DOI 10.1002/ijc.1440
-
Parkin DM, Bray F, Ferlay J, et al. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94: 153-6. (Pubitemid 32911406)
-
(2001)
International Journal of Cancer
, vol.94
, Issue.2
, pp. 153-156
-
-
Maxwell Parkin, D.1
Bray, F.2
Ferlay, J.3
Pisani, P.4
-
2
-
-
34250020201
-
Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
-
DOI 10.1053/j.gastro.2007.04.061, PII S0016508507007998
-
El-Serag HB, Rudolph KL,. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132: 2557-76. (Pubitemid 46890874)
-
(2007)
Gastroenterology
, vol.132
, Issue.7
, pp. 2557-2576
-
-
El-Serag, H.B.1
Rudolph, K.L.2
-
3
-
-
84984552538
-
Viral hepatocarcinogenesis: From infection to cancer
-
DOI 10.1111/j.1478-3231.2007.01652.x
-
Tan A, Yeh SH, Liu CJ, et al. Viral hepatocarcinogenesis: from infection to cancer. Liver Int 2008; 28: 175-88. (Pubitemid 351201032)
-
(2008)
Liver International
, vol.28
, Issue.2
, pp. 175-188
-
-
Tan, A.1
Yeh, S.-H.2
Liu, C.-J.3
Cheung, C.4
Chen, P.-J.5
-
4
-
-
67651151325
-
Current management strategy of hepatocellular carcinoma
-
Rampone B, Schiavone B, Martino A, et al. Current management strategy of hepatocellular carcinoma. World J Gastroenterol 2009; 15: 3210-6.
-
(2009)
World J Gastroenterol
, vol.15
, pp. 3210-3216
-
-
Rampone, B.1
Schiavone, B.2
Martino, A.3
-
6
-
-
64949153532
-
The current role of neoadjuvant/adjuvant/chemoprevention therapy in partial hepatectomy for hepatocellular carcinoma: A systematic review
-
Lau WY, Lai EC, Lau SH,. The current role of neoadjuvant/adjuvant/ chemoprevention therapy in partial hepatectomy for hepatocellular carcinoma: A systematic review. Hepatobiliary Pancreat Dis Int 2009; 8: 124-33.
-
(2009)
Hepatobiliary Pancreat Dis Int
, vol.8
, pp. 124-133
-
-
Lau, W.Y.1
Lai, E.C.2
Lau, S.H.3
-
7
-
-
54449083925
-
Molecular targeted therapies in hepatocellular carcinoma
-
Llovet JM, Bruix J,. Molecular targeted therapies in hepatocellular carcinoma. Hepatology 2008; 48: 1312-27.
-
(2008)
Hepatology
, vol.48
, pp. 1312-1327
-
-
Llovet, J.M.1
Bruix, J.2
-
8
-
-
47949116252
-
Sorafenib in advanced hepatocellular carcinoma
-
Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008; 359: 378-90.
-
(2008)
N Engl J Med
, vol.359
, pp. 378-390
-
-
Llovet, J.M.1
Ricci, S.2
Mazzaferro, V.3
-
9
-
-
33847390325
-
Telomerase-specific oncolytic virotherapy for human cancer with the hTERT promoter
-
DOI 10.2174/156800907780058835
-
Fujiwara T, Urata Y, Tanaka N,. Telomerase-specific oncolytic virotherapy for human cancer with the hTERT promoter. Curr Cancer Drug Targets 2007; 7: 191-201. (Pubitemid 46348634)
-
(2007)
Current Cancer Drug Targets
, vol.7
, Issue.2
, pp. 191-201
-
-
Fujiwara, T.1
Urata, Y.2
Tanaka, N.3
-
10
-
-
1642576131
-
Telomerase-specific replication-selective virotherapy for human cancer
-
DOI 10.1158/1078-0432.CCR-1075-3
-
Kawashima T, Kagawa S, Kobayashi N, et al. Telomerase-specific replication-selective virotherapy for human cancer. Clin Cancer Res 2004; 10: 285-92. (Pubitemid 38114191)
-
(2004)
Clinical Cancer Research
, vol.10
, Issue.1
, pp. 285-292
-
-
Kawashima, T.1
Kagawa, S.2
Kobayashi, N.3
Shirakiya, Y.4
Umeoka, T.5
Teraishi, F.6
Taki, M.7
Kyo, S.8
Tanaka, N.9
Fujiwara, T.10
-
11
-
-
0038745637
-
A telomerase-dependent conditionally replicating adenovirus for selective treatment of cancer
-
Wirth T, Zender L, Schulte B, et al. A telomerase-dependent conditionally replicating adenovirus for selective treatment of cancer. Cancer Res 2003; 63: 3181-8. (Pubitemid 36735870)
-
(2003)
Cancer Research
, vol.63
, Issue.12
, pp. 3181-3188
-
-
Wirth, T.1
Zender, L.2
Schulte, B.3
Mundt, B.4
Plentz, R.5
Lenhard Rudolph, K.6
Manns, M.7
Kubicka, S.8
Kuhnel, F.9
-
12
-
-
0042674013
-
Telomerase-dependent oncolytic adenovirus for cancer treatment
-
DOI 10.1038/sj.gt.3301987
-
Huang TG, Savontaus MJ, Shinozaki K, et al. Telomerase-dependent oncolytic adenovirus for cancer treatment. Gene Ther 2003; 10: 1241-7. (Pubitemid 36934726)
-
(2003)
Gene Therapy
, vol.10
, Issue.15
, pp. 1241-1247
-
-
Huang, T.-G.1
Savontaus, M.J.2
Shinozaki, K.3
Sauter, B.V.4
Woo, S.L.C.5
-
13
-
-
76349086193
-
A phase i Study of telomerase-specific replication competent oncolytic adenovirus (telomelysin) for various solid tumors
-
Nemunaitis J, Tong AW, Nemunaitis M, et al. A phase I Study of telomerase-specific replication competent oncolytic adenovirus (telomelysin) for various solid tumors. Mol Ther 2010; 18: 429-34.
-
(2010)
Mol Ther
, vol.18
, pp. 429-434
-
-
Nemunaitis, J.1
Tong, A.W.2
Nemunaitis, M.3
-
14
-
-
0034632682
-
Immuno-histochemical detection of human telomerase reverse transcriptase in human liver tissues
-
Kawakami Y, Kitamoto M, Nakanishi T, et al. Immuno-histochemical detection of human telomerase reverse transcriptase in human liver tissues. Oncogene 2000; 19: 3888-93. (Pubitemid 30658979)
-
(2000)
Oncogene
, vol.19
, Issue.34
, pp. 3888-3893
-
-
Kawakami, Y.1
Kitamoto, M.2
Nakanishi, T.3
Yasui, W.4
Tahara, E.5
Nakayama, J.-I.6
Ishikawa, F.7
Tahara, H.8
Ide, T.9
Kajiyama, G.10
-
15
-
-
41949104575
-
Direct and distant antitumor effects of a telomerase-selective oncolytic adenoviral agent, OBP-301, in a mouse prostate cancer model
-
DOI 10.1038/cgt.2008.3, PII CGT20083
-
Huang P, Watanabe M, Kaku H, et al. Direct and distant antitumor effects of a telomerase-selective oncolytic adenoviral agent, OBP-301, in a mouse prostate cancer model. Cancer Gene Ther 2008; 15: 315-22. (Pubitemid 351508138)
-
(2008)
Cancer Gene Therapy
, vol.15
, Issue.5
, pp. 315-322
-
-
Huang, P.1
Watanabe, M.2
Kaku, H.3
Kashiwakura, Y.4
Chen, J.5
Saika, T.6
Nasu, Y.7
Fujiwara, T.8
Urata, Y.9
Kumon, H.10
-
16
-
-
42549129252
-
Combination of oncolytic adenovirotherapy and Bax gene therapy in human cancer xenografted models. Potential merits and hurdles for combination therapy
-
DOI 10.1002/ijc.23438
-
Hioki M, Kagawa S, Fujiwara T, et al. Combination of oncolytic adenovirotherapy and Bax gene therapy in human cancer xenografted models. Potential merits and hurdles for combination therapy. Int J Cancer 2008; 122: 2628-33. (Pubitemid 351590501)
-
(2008)
International Journal of Cancer
, vol.122
, Issue.11
, pp. 2628-2633
-
-
Hioki, M.1
Kagawa, S.2
Fujiwara, T.3
Sakai, R.4
Kojima, T.5
Watanabe, Y.6
Hashimoto, Y.7
Uno, F.8
Tanaka, N.9
Fujiwara, T.10
-
17
-
-
35748984654
-
Immunocompetent syngeneic cotton rat tumor models for the assessment of replication-competent oncolytic adenovirus
-
DOI 10.1016/j.virol.2007.07.022, PII S0042682207004916
-
Steel JC, Morrison BJ, Mannan P, et al. Immunocompetent syngeneic cotton rat tumor models for the assessment of replication-competent oncolytic adenovirus. Virology 2007; 369: 131-42. (Pubitemid 350047474)
-
(2007)
Virology
, vol.369
, Issue.1
, pp. 131-142
-
-
Steel, J.C.1
Morrison, B.J.2
Mannan, P.3
Abu-Asab, M.S.4
Wildner, O.5
Miles, B.K.6
Yim, K.C.7
Ramanan, V.8
Prince, G.A.9
Morris, J.C.10
-
18
-
-
64049109524
-
Novel immunocompetent murine tumor model for evaluation of conditionally replication-competent (oncolytic) murine adenoviral vectors
-
Robinson M, Li B, Ge Y, et al. Novel immunocompetent murine tumor model for evaluation of conditionally replication-competent (oncolytic) murine adenoviral vectors. J Virol 2009; 83: 3450-62.
-
(2009)
J Virol
, vol.83
, pp. 3450-3462
-
-
Robinson, M.1
Li, B.2
Ge, Y.3
-
19
-
-
50549091297
-
The targeted oncolytic poxvirus JX-594 demonstrates antitumoral, antivascular, and anti-HBV activities in patients with hepatocellular carcinoma
-
Liu TC, Hwang T, Park BH, et al. The targeted oncolytic poxvirus JX-594 demonstrates antitumoral, antivascular, and anti-HBV activities in patients with hepatocellular carcinoma. Mol Ther 2008; 16: 1637-42.
-
(2008)
Mol Ther
, vol.16
, pp. 1637-1642
-
-
Liu, T.C.1
Hwang, T.2
Park, B.H.3
-
20
-
-
44249100151
-
Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: A phase i trial
-
Park BH, Hwang T, Liu TC, et al. Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: A phase I trial. Lancet Oncol 2008; 9: 533-42.
-
(2008)
Lancet Oncol
, vol.9
, pp. 533-542
-
-
Park, B.H.1
Hwang, T.2
Liu, T.C.3
-
21
-
-
60549100362
-
Antitumoral immune response by recruitment and expansion of dendritic cells in tumors infected with telomerase-dependent oncolytic viruses
-
Edukulla R, Woller N, Mundt B, et al. Antitumoral immune response by recruitment and expansion of dendritic cells in tumors infected with telomerase-dependent oncolytic viruses. Cancer Res 2009; 69: 1448-58.
-
(2009)
Cancer Res
, vol.69
, pp. 1448-1458
-
-
Edukulla, R.1
Woller, N.2
Mundt, B.3
-
22
-
-
78049463446
-
Selectivity of oncolytic viral replication prevents antiviral immune response and toxicity, but does not improve antitumoral immunity
-
Gurlevik E, Woller N, Struver N, et al. Selectivity of oncolytic viral replication prevents antiviral immune response and toxicity, but does not improve antitumoral immunity. Mol Ther 2010; 18: 1972-82.
-
(2010)
Mol Ther
, vol.18
, pp. 1972-1982
-
-
Gurlevik, E.1
Woller, N.2
Struver, N.3
-
23
-
-
31544471137
-
Effect of adenovirus-mediated heat shock protein expression and oncolysis in combination with low-dose cyclophosphamide treatment on antitumor immune responses
-
DOI 10.1158/0008-5472.CAN-05-2388
-
Di Paolo NC, Tuve S, Ni S, et al. Effect of adenovirus-mediated heat shock protein expression and oncolysis in combination with low-dose cyclophosphamide treatment on antitumor immune responses. Cancer Res 2006; 66: 960-9. (Pubitemid 43165964)
-
(2006)
Cancer Research
, vol.66
, Issue.2
, pp. 960-969
-
-
Di Paolo, N.C.1
Tuve, S.2
Ni, S.3
Hellstrom, K.E.4
Hellstrom, I.5
Lieber, A.6
-
24
-
-
33750332951
-
Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model
-
Lee YS, Kim JH, Choi KJ, et al. Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model. Clin Cancer Res 2006; 12: 5859-68.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 5859-5868
-
-
Lee, Y.S.1
Kim, J.H.2
Choi, K.J.3
-
25
-
-
30144444237
-
Blocking of G1/S transition and cell death in the regenerating liver of Hepatitis B virus X protein transgenic mice
-
Wu BK, Li CC, Chen HJ, et al. Blocking of G1/S transition and cell death in the regenerating liver of Hepatitis B virus X protein transgenic mice. Biochem Biophys Res Commun 2006; 340: 916-28.
-
(2006)
Biochem Biophys Res Commun
, vol.340
, pp. 916-928
-
-
Wu, B.K.1
Li, C.C.2
Chen, H.J.3
-
26
-
-
33749525340
-
In vivo imaging of lymph node metastasis with telomerase-specific replication-selective adenovirus
-
DOI 10.1038/nm1404, PII NM1404
-
Kishimoto H, Kojima T, Watanabe Y, et al. In vivo imaging of lymph node metastasis with telomerase-specific replication-selective adenovirus. Nat Med 2006; 12: 1213-9. (Pubitemid 44527360)
-
(2006)
Nature Medicine
, vol.12
, Issue.10
, pp. 1213-1219
-
-
Kishimoto, H.1
Kojima, T.2
Watanabe, Y.3
Kagawa, S.4
Fujiwara, T.5
Uno, F.6
Teraishi, F.7
Kyo, S.8
Mizuguchi, H.9
Hashimoto, Y.10
Urata, Y.11
Tanaka, N.12
Fujiwara, T.13
-
27
-
-
84984563004
-
Allelic loss of chromosome 4q21 approximately 23 associates with hepatitis B virus-related hepatocarcinogenesis and elevated alpha-fetoprotein
-
Yeh SH, Lin MW, Lu SF, et al. Allelic loss of chromosome 4q21 approximately 23 associates with hepatitis B virus-related hepatocarcinogenesis and elevated alpha-fetoprotein. Hepatology 2004; 40: 847-54.
-
(2004)
Hepatology
, vol.40
, pp. 847-854
-
-
Yeh, S.H.1
Lin, M.W.2
Lu, S.F.3
-
28
-
-
84983725887
-
Chromosomal allelic imbalance evolving from liver cirrhosis to hepatocellular carcinoma
-
Yeh SH, Chen PJ, Shau WY, et al. Chromosomal allelic imbalance evolving from liver cirrhosis to hepatocellular carcinoma. Gastroenterology 2001; 121: 699-709.
-
(2001)
Gastroenterology
, vol.121
, pp. 699-709
-
-
Yeh, S.H.1
Chen, P.J.2
Shau, W.Y.3
-
29
-
-
84984572980
-
Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis
-
Yeh SH, Tsai CY, Kao JH, et al. Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis. J Hepatol 2004; 41: 659-66.
-
(2004)
J Hepatol
, vol.41
, pp. 659-666
-
-
Yeh, S.H.1
Tsai, C.Y.2
Kao, J.H.3
-
30
-
-
0022635768
-
Restricted replication of adenovirus type 2 in mouse Balb/3T3 cells
-
DOI 10.1007/BF01315303
-
Silverstein G, Strohl WA,. Restricted replication of adenovirus type 2 in mouse Balb/3T3 cells. Arch Virol 1986; 87: 241-64. (Pubitemid 16180329)
-
(1986)
Archives of Virology
, vol.87
, Issue.3-4
, pp. 241-264
-
-
Silverstein, G.1
Strohl, W.A.2
-
31
-
-
0022658185
-
Molecular biology of adenovirus type 2 semipermissive infections. I. Viral growth and expression of viral replicative functions during restricted adenovirus infection
-
DOI 10.1016/0042-6822(86)90406-X
-
Eggerding FA, Pierce WC,. Molecular biology of adenovirus type 2 semipermissive infections. I. Viral growth and expression of viral replicative functions during restricted adenovirus infection. Virology 1986; 148: 97-113. (Pubitemid 16186643)
-
(1986)
Virology
, vol.148
, Issue.1
, pp. 97-113
-
-
Eggerding, F.A.1
Pierce, W.C.2
-
32
-
-
40549146594
-
Telomerase-specific oncolytic virotherapy for human hepatocellular carcinoma
-
Li YM, Song ST, Jiang ZF, et al. Telomerase-specific oncolytic virotherapy for human hepatocellular carcinoma. World J Gastroenterol 2008; 14: 1274-9.
-
(2008)
World J Gastroenterol
, vol.14
, pp. 1274-1279
-
-
Li, Y.M.1
Song, S.T.2
Jiang, Z.F.3
-
33
-
-
0142089747
-
Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer
-
DOI 10.1016/j.ymgme.2003.08.016
-
Raper SE, Chirmule N, Lee FS, et al. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab 2003; 80: 148-58. (Pubitemid 37272241)
-
(2003)
Molecular Genetics and Metabolism
, vol.80
, Issue.1-2
, pp. 148-158
-
-
Raper, S.E.1
Chirmule, N.2
Lee, F.S.3
Wivel, N.A.4
Bagg, A.5
Gao, G.-P.6
Wilson, J.M.7
Batshaw, M.L.8
-
34
-
-
38849134279
-
Adenovirus serotype 5 hexon mediates liver gene transfer
-
DOI 10.1016/j.cell.2008.01.016, PII S0092867408001165
-
Waddington SN, McVey JH, Bhella D, et al. Adenovirus serotype 5 hexon mediates liver gene transfer. Cell 2008; 132: 397-409. (Pubitemid 351200513)
-
(2008)
Cell
, vol.132
, Issue.3
, pp. 397-409
-
-
Waddington, S.N.1
McVey, J.H.2
Bhella, D.3
Parker, A.L.4
Barker, K.5
Atoda, H.6
Pink, R.7
Buckley, S.M.K.8
Greig, J.A.9
Denby, L.10
Custers, J.11
Morita, T.12
Francischetti, I.M.B.13
Monteiro, R.Q.14
Barouch, D.H.15
Van Rooijen, N.16
Napoli, C.17
Havenga, M.J.E.18
Nicklin, S.A.19
Baker, A.H.20
more..
-
35
-
-
44349193581
-
Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo
-
DOI 10.1073/pnas.0711757105
-
Kalyuzhniy O, Di Paolo NC, Silvestry M, et al. Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo. Proc Natl Acad Sci USA 2008; 105: 5483-8. (Pubitemid 351753889)
-
(2008)
Proceedings of the National Academy of Sciences of the United States of America
, vol.105
, Issue.14
, pp. 5483-5488
-
-
Kalyuzhniy, O.1
Di Paolo, N.C.2
Silvestry, M.3
Hofherr, S.E.4
Barry, M.A.5
Stewart, P.L.6
Shayakhmetov, D.M.7
-
36
-
-
34248141100
-
A cytokine-mediated link between innate immunity, inflammation, and cancer
-
DOI 10.1172/JCI31537
-
Lin WW, Karin M,. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Investig 2007; 117: 1175-83. (Pubitemid 46718402)
-
(2007)
Journal of Clinical Investigation
, vol.117
, Issue.5
, pp. 1175-1183
-
-
Lin, W.-W.1
Karin, M.2
|